Orion Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Orion Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,500	Closed	-$5.34K	–	489
2025 Q4	$5.34K	Hold	1,500	–	–	﹤0.01%	425
2025 Q3	$13.3K	Hold	1,500	–	–	﹤0.01%	369
2025 Q2	$13.8K	Hold	1,500	–	–	0.01%	345
2025 Q1	$12.9K	Hold	1,500	–	–	0.01%	341
2024 Q4	$16.1K	Sell	1,500 -10,000	-87%	-$76.9K	0.01%	338
2024 Q3	$65.3K	Buy	11,500 +10,000	+667%	+$57.7K	0.03%	128
2024 Q2	$6.33K	Sell	1,500 -7,000	-82%	-$28.3K	﹤0.01%	368
2024 Q1	$43.3K	Hold	8,500	–	–	0.02%	260
2023 Q4	$79.1K	Sell	8,500 -500	-6%	-$3.44K	0.05%	190
2023 Q3	$59K	Buy	+9,000	New	+$71.6K	0.04%	203
2023 Q2	–	Sell	-9,500	Closed	-$81.4K	–	167
2023 Q1	$81.4K	Hold	9,500	–	–	0.05%	175
2022 Q4	$88K	Hold	9,500	–	–	0.06%	157
2022 Q3	$98K	Hold	9,500	–	–	0.08%	147
2022 Q2	$95K	Hold	9,500	–	–	0.07%	153
2022 Q1	$117K	Hold	9,500	–	–	0.07%	158
2021 Q4	$165K	Sell	9,500 -1,000	-10%	-$19K	0.09%	131
2021 Q3	$188K	Buy	10,500 +200	+2%	+$3.98K	0.11%	116
2021 Q2	$235K	Sell	10,300 -500	-5%	-$7.41K	0.15%	101
2021 Q1	$161K	Sell	10,800 -200	-2%	-$2.18K	0.11%	112
2020 Q4	$59K	Buy	+11,000	New	+$58K	0.04%	147

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Orion Capital Management's AVXL Position: Q1 2026 in Review

Orion Capital Management sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 1,500 shares — an estimated $5.34K sold.

Orion Capital Management first reported a position in AVXL in Q4 2020 and held it in 20 quarters. The position peaked at $235K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Orion Capital Management reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
Orion Capital Management sold 1,500 Anavex Life Sciences shares in Q1 2026, an estimated $5.34K.
Orion Capital Management first reported a position in Anavex Life Sciences in Q4 2020 and held it in 20 quarters.
Orion Capital Management's Anavex Life Sciences position peaked at $235K in Q2 2021.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.